Research from Asahikawa Medical University Yields New Findings on Sepsis (Current Perspectives of Mitochondria in Sepsis-Induced Cardiomyopathy).

A recent report from Asahikawa Medical University in Japan discusses the role of mitochondria in sepsis-induced cardiomyopathy (SICM), a condition associated with poor prognosis in sepsis patients. The research highlights the impact of severe sepsis on mitochondrial structure and function, leading to ATP depletion and metabolic disruption in cardiomyocytes. The study emphasizes the need for effective treatment options for sepsis-induced myocardial injury, as inotropic drugs are not effective due to excessive inflammatory factors. The report provides current knowledge on myocardial cell death in sepsis and its molecular mechanisms, with a focus on the potential for developing therapies for SICM. [Extracted from the article]

Copyright of Cardiovascular Week is the property of NewsRx and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)